CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Histogen Inc. - HSTO CFD

1.0367
6.11%
0.0766
Low: 0.977
High: 1.0667
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Ownership
Trading Conditions
Spread 0.0766
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0308%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0137%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.977
Open* 0.9771
1-Year Change* -5.14%
Day's Range* 0.977 - 0.977
52 wk Range 0.15-1.23
Average Volume (10 days) N/A
Average Volume (3 months) 64.4465
Market Cap 7.97705
P/E Ratio N/A
Shares Outstanding 49950200
Revenue 1.032
EPS -0.40004
Dividend (Yield %) N/A
Beta 0.96446
Next Earnings Date Aug 9, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 25, 2022 1.0368 0.0598 6.12% 0.9770 1.0667 0.9770
Nov 23, 2022 0.9770 -0.0099 -1.00% 0.9869 0.9869 0.9525
Nov 22, 2022 0.9670 0.0031 0.32% 0.9639 1.0168 0.9347
Nov 21, 2022 0.9289 -0.0779 -7.74% 1.0068 1.0268 0.8872
Nov 18, 2022 1.0069 0.0001 0.01% 1.0068 1.0368 0.9670
Nov 17, 2022 1.0368 0.0001 0.01% 1.0367 1.0767 1.0168
Nov 16, 2022 1.0866 0.0200 1.88% 1.0666 1.1564 1.0567
Nov 15, 2022 1.0667 -0.0598 -5.31% 1.1265 1.1464 1.0367
Nov 14, 2022 1.1065 0.0398 3.73% 1.0667 1.1564 1.0567
Nov 11, 2022 1.0468 0.0300 2.95% 1.0168 1.0567 0.9969
Nov 10, 2022 1.0168 -0.0100 -0.97% 1.0268 1.0268 0.9470
Nov 9, 2022 1.0866 0.0798 7.93% 1.0068 1.6051 0.9969
Nov 8, 2022 0.9792 0.0023 0.24% 0.9769 0.9869 0.9467
Nov 7, 2022 0.9670 -0.1794 -15.65% 1.1464 1.1465 0.9370
Nov 4, 2022 1.0767 -0.1096 -9.24% 1.1863 1.1863 1.0567
Nov 3, 2022 1.1564 -0.0199 -1.69% 1.1763 1.1963 1.1464
Nov 2, 2022 1.2063 -0.0797 -6.20% 1.2860 1.2960 1.1863
Nov 1, 2022 1.2661 -0.0398 -3.05% 1.3059 1.3259 1.2461
Oct 31, 2022 1.3059 0.0299 2.34% 1.2760 1.3359 1.2660
Oct 28, 2022 1.2661 -0.0199 -1.55% 1.2860 1.3159 1.2561

Histogen Inc. Events

Time (UTC) Country Event
No events scheduled
View all events

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Histogen Inc. Company profile

Histogen Inc., a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company''s pre-clinical programs include HST-004, a cell conditioned media (CCM) solution to treat spinal disc repair; and HST-002, a human-derived collagen and extracellular matrix dermal filler for the treatment of facial folds and wrinkles. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.
Industry: Bio Therapeutic Drugs

10655 Sorrento Valley Road
Suite 200
92121

People also watch

Oil - Crude

74.31 Price
-3.100% 1D Chg, %
Long position overnight fee -0.0085%
Short position overnight fee -0.0063%
Overnight fee time 22:00 (UTC)
Spread 0.03

US100

11,668.50 Price
-0.740% 1D Chg, %
Long position overnight fee -0.0167%
Short position overnight fee 0.0060%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.38 Price
-5.190% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00317

BTC/USD

16,226.30 Price
-2.300% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 60.00

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading